Quantcast
Home > Quotes > ABBV

AbbVie Inc. Common Stock (ABBV) Quote & Summary Data

ABBV 
$84.02
*  
0.48
0.57%
Get ABBV Alerts
*Delayed - data as of Jan. 27, 2020  -  Find a broker to begin trading ABBV now
Exchange:NYSE
Industry: Health Care
View:    ABBV Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

1 Year Target
95.5
Today's High / Low
$ 85.93 / $ 84
Share Volume
13,773,613
90 Day Avg. Daily Volume
7,842,199
Previous Close
$ 83.54
52 Week High / Low
$ 91.99 / $ 62.66
Market Cap
124,250,549,578
P/E Ratio
38.72
Forward P/E (1y)
9.41
Earnings Per Share (EPS)
$ 2.17
Annualized Dividend
$ 4.72
Ex Dividend Date
1/14/2020
Dividend Payment Date
2/14/2020
Current Yield
5.65 %
Beta
1

Intraday Chart

Shares Traded

Share Volume:
13,773,613
90 Day Avg. Daily Volume:
7,842,199

P/E Ratio

P/E Ratio:
38.72
Forward P/E (1y):
9.41
Earnings Per Share (EPS):
$ 2.17

Trading Range

The current last sale of $84.02 is 34.09% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 85.93 $ 91.99
 Low: $ 84 $ 62.66

ETFs with ABBV as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
5.29% AdvisorShares Vice ETF (ACT) +1.15 (4.81%)
4.82% Invesco Exchange-Traded Fund Trust II Invesco S&P Ultra Divide (RDIV) +2.59 (7.31%)
4.65% Invesco Dynamic Biotech & Genome ETF (PBE) +6.17 (12.56%)
4.65% Invesco Dynamic Pharmaceuticals ETF (PJP) +8.21 (14.73%)
4.53% iShares U.S. ETF Trust (IEIH) +3.15 (12.94%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

AbbVie(1) is a global, research-based biopharmaceutical company. AbbVie develops and markets advanced therapies that address some of the world's most complex and serious diseases. AbbVie's products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; as well as other serious health conditions. AbbVie also has a pipeline of promising new medicines in clinical development across such important medical specialties as immunology, oncology and neuroscience, with additional targeted investment in cystic fibrosis and women's health. AbbVie was incorporated in Delaware on April 10, 2012.  ... More ...  



Risk Grade

Where does ABBV fit in the risk graph?


Risk Grade Scale



Consensus Recommendation

Analyst Info